The ELISA PBC screen was positive in 155 out of 164 (94.5%) PBC patients; moreover, 146 (89.0%), 28 (17.1%), and 31 (18.9%) patients, respectively, tested positive for MIT3, sp100, and gp210 using specific ELISA tests. Here, SP100 is linked to primary biliary cholangitis.